301 related articles for article (PubMed ID: 10799580)
1. Cell fusion activity of hepatitis C virus envelope proteins.
Takikawa S; Ishii K; Aizaki H; Suzuki T; Asakura H; Matsuura Y; Miyamura T
J Virol; 2000 Jun; 74(11):5066-74. PubMed ID: 10799580
[TBL] [Abstract][Full Text] [Related]
2. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.
Flint M; Thomas JM; Maidens CM; Shotton C; Levy S; Barclay WS; McKeating JA
J Virol; 1999 Aug; 73(8):6782-90. PubMed ID: 10400776
[TBL] [Abstract][Full Text] [Related]
4. Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81.
Tian ZF; Shen H; Fu XH; Chen YC; Blum HE; Baumert TF; Zhao XP
World J Gastroenterol; 2009 Jan; 15(2):240-4. PubMed ID: 19132776
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer.
Meyer K; Beyene A; Bowlin TL; Basu A; Ray R
J Virol; 2004 Dec; 78(23):12838-47. PubMed ID: 15542636
[TBL] [Abstract][Full Text] [Related]
6. Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis.
Codran A; Royer C; Jaeck D; Bastien-Valle M; Baumert TF; Kieny MP; Pereira CA; Martin JP
J Gen Virol; 2006 Sep; 87(Pt 9):2583-2593. PubMed ID: 16894197
[TBL] [Abstract][Full Text] [Related]
7. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.
Lagging LM; Meyer K; Owens RJ; Ray R
J Virol; 1998 May; 72(5):3539-46. PubMed ID: 9557633
[TBL] [Abstract][Full Text] [Related]
8. Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface.
Forns X; Allander T; Rohwer-Nutter P; Bukh J
Virology; 2000 Aug; 274(1):75-85. PubMed ID: 10936090
[TBL] [Abstract][Full Text] [Related]
9. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C; McKeating J; Scarselli E
J Virol; 2000 Jul; 74(13):5933-8. PubMed ID: 10846074
[TBL] [Abstract][Full Text] [Related]
10. Binding of hepatitis C virus to CD81.
Pileri P; Uematsu Y; Campagnoli S; Galli G; Falugi F; Petracca R; Weiner AJ; Houghton M; Rosa D; Grandi G; Abrignani S
Science; 1998 Oct; 282(5390):938-41. PubMed ID: 9794763
[TBL] [Abstract][Full Text] [Related]
11. Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81.
Drummer HE; Wilson KA; Poumbourios P
J Virol; 2002 Nov; 76(21):11143-7. PubMed ID: 12368358
[TBL] [Abstract][Full Text] [Related]
12. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.
Higginbottom A; Quinn ER; Kuo CC; Flint M; Wilson LH; Bianchi E; Nicosia A; Monk PN; McKeating JA; Levy S
J Virol; 2000 Apr; 74(8):3642-9. PubMed ID: 10729140
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.
Wünschmann S; Medh JD; Klinzmann D; Schmidt WN; Stapleton JT
J Virol; 2000 Nov; 74(21):10055-62. PubMed ID: 11024134
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the subcellular localization of hepatitis C virus E2 glycoprotein in live cells using EGFP fusion proteins.
Kien F; Abraham JD; Schuster C; Kieny MP
J Gen Virol; 2003 Mar; 84(Pt 3):561-566. PubMed ID: 12604806
[TBL] [Abstract][Full Text] [Related]
15. The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system.
Basu A; Beyene A; Meyer K; Ray R
J Virol; 2004 May; 78(9):4478-86. PubMed ID: 15078928
[TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding.
Patel AH; Wood J; Penin F; Dubuisson J; McKeating JA
J Gen Virol; 2000 Dec; 81(Pt 12):2873-2883. PubMed ID: 11086118
[TBL] [Abstract][Full Text] [Related]
17. Development of an infectious surrogate hepatitis C virus based on a recombinant vesicular stomatitis virus expressing hepatitis C virus envelope glycoproteins and green fluorescent protein.
Okuma K; Fukagawa K; Tateyama S; Kohma T; Mochida K; Hiyoshi M; Takahama Y; Hamaguchi Y; Hirose K; Buonocore L; Rose JK; Mizuochi T; Hamaguchi I
Jpn J Infect Dis; 2015; 68(3):203-8. PubMed ID: 25672345
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of the ectodomain of E2 envelope glycoprotein of hepatitis C virus folded in the presence of full-length E1 glycoprotein.
Ortega-Atienza S; Lombana L; Gómez-Gutiérrez J; Yélamos B; Peterson DL; Gavilanes F
Protein Expr Purif; 2014 Dec; 104():20-5. PubMed ID: 25255721
[TBL] [Abstract][Full Text] [Related]
19. The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor.
Masciopinto F; Campagnoli S; Abrignani S; Uematsu Y; Pileri P
Virus Res; 2001 Nov; 80(1-2):1-10. PubMed ID: 11597743
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.
Owsianka A; Clayton RF; Loomis-Price LD; McKeating JA; Patel AH
J Gen Virol; 2001 Aug; 82(Pt 8):1877-1883. PubMed ID: 11457993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
